Literature DB >> 28529188

GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence.

Gordon H Guyatt1, Shanil Ebrahim2, Pablo Alonso-Coello3, Bradley C Johnston4, Alexander G Mathioudakis5, Matthias Briel6, Reem A Mustafa7, Xin Sun8, Stephen D Walter9, Diane Heels-Ansdell9, Ignacio Neumann10, Lara A Kahale11, Alfonso Iorio1, Joerg Meerpohl12, Holger J Schünemann1, Elie A Akl13.   

Abstract

OBJECTIVE: To provide GRADE guidance for assessing risk of bias across an entire body of evidence consequent on missing data for systematic reviews of both binary and continuous outcomes. STUDY DESIGN AND
SETTING: Systematic survey of published methodological research, iterative discussions, testing in systematic reviews, and feedback from the GRADE Working Group.
RESULTS: Approaches begin with a primary meta-analysis using a complete case analysis followed by sensitivity meta-analyses imputing, in each study, data for those with missing data, and then pooling across studies. For binary outcomes, we suggest use of "plausible worst case" in which review authors assume that those with missing data in treatment arms have proportionally higher event rates than those followed successfully. For continuous outcomes, imputed mean values come from other studies within the systematic review and the standard deviation (SD) from the median SDs of the control arms of all studies.
CONCLUSIONS: If the results of the primary meta-analysis are robust to the most extreme assumptions viewed as plausible, one does not rate down certainty in the evidence for risk of bias due to missing participant outcome data. If the results prove not robust to plausible assumptions, one would rate down certainty in the evidence for risk of bias.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GRADE; Missing participant data; Risk of bias; Systematic reviews; Trials

Mesh:

Year:  2017        PMID: 28529188     DOI: 10.1016/j.jclinepi.2017.05.005

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  53 in total

1.  Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.

Authors:  Ning Liang; De Zhao Kong; Si Si Ma; Chun Li Lu; Ming Yang; Lu Da Feng; Chen Shen; Ruo Han Diao; Ling Jun Cui; Xing Yu Lu; Dimitrinka Nikolova; Janus C Jakobsen; Christian Gluud; Jian Ping Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-04-03

2.  A Theoretical Framework and Competency-Based Approach to Training in Guideline Development.

Authors:  Shahnaz Sultan; Rebecca L Morgan; M Hassan Murad; Yngve Falck-Ytter; Philipp Dahm; Holger J Schünemann; Reem A Mustafa
Journal:  J Gen Intern Med       Date:  2019-11-14       Impact factor: 5.128

Review 3.  Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Authors:  Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Charbel F Matar; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Francesca Sperati; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2017-12-29

4.  DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines.

Authors:  Ignacio Neumann; Ariel Izcovich; Yuqing Zhang; Gabriel Rada; Susan R Kahn; Frederick Spencer; Suely Rezende; Franchesco Dentali; Kenneth Bauer; Gian Paolo Morgano; Juan J Yepes-Nuñez; Robby Nieuwlaat; Wojtek Wiercioch; Liming Lu; Jiaming Wu; Mary Cushman; Holger Schunemann
Journal:  Blood Adv       Date:  2020-04-14

5.  Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.

Authors:  Ariel Izcovich; Juan M Criniti; Federico Popoff; Liming Lu; Jiaming Wu; Walter Ageno; Daniel M Witt; Michael R Jaff; Sam Schulman; Veena Manja; Peter Verhamme; Gabriel Rada; Yuqing Zhang; Robby Nieuwlaat; Wojtek Wiercioch; Holger J Schünemann; Ignacio Neumann
Journal:  Blood Adv       Date:  2020-04-14

6.  Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.

Authors:  Omar Abdel-Rahman; Zeinab Elsayed
Journal:  Cochrane Database Syst Rev       Date:  2020-01-24

7.  GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.

Authors:  Holger J Schünemann; Carlos Cuello; Elie A Akl; Reem A Mustafa; Jörg J Meerpohl; Kris Thayer; Rebecca L Morgan; Gerald Gartlehner; Regina Kunz; S Vittal Katikireddi; Jonathan Sterne; Julian Pt Higgins; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2018-02-09       Impact factor: 6.437

8.  Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.

Authors:  Sadia Janjua; Alexander G Mathioudakis; Rebecca Fortescue; Ruth Ae Walker; Sahar Sharif; Christopher Jd Threapleton; Sofia Dias
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

9.  Biofeedback for treatment of irritable bowel syndrome.

Authors:  Joshua Z Goldenberg; Matthew Brignall; Michelle Hamilton; Jennifer Beardsley; Richard D Batson; Jason Hawrelak; Brad Lichtenstein; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2019-11-12

10.  Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank.

Authors:  Alexander G Mathioudakis; Michael Miligkos; Cristina Boccabella; Gioulinta S Alimani; Adnan Custovic; A Deschildre; Francine Monique Ducharme; Omer Kalayci; Clare Murray; Antonio Nieto Garcia; Wanda Phipatanakul; David Price; Aziz Sheikh; Ioana Octavia Agache; Leonard Bacharier; Apostolos Beloukas; Andrew Bentley; Matteo Bonini; Jose A Castro-Rodriguez; Giuseppe De Carlo; Timothy Craig; Zuzana Diamant; Wojciech Feleszko; Tim Felton; James E Gern; Jonathan Grigg; Gunilla Hedlin; Elham M Hossny; Despo Ierodiakonou; Tuomas Jartti; Alan Kaplan; Robert F Lemanske; Peter N Le Souëf; Mika J Mäkelä; Georgios A Mathioudakis; Paolo Matricardi; Marina Mitrogiorgou; Mario Morais-Almeida; Karthik Nagaraju; Effie Papageorgiou; Helena Pité; Paulo M C Pitrez; Petr Pohunek; Graham Roberts; Ioanna Tsiligianni; Stephen Turner; Susanne Vijverberg; Tonya A Winders; Gary Wk Wong; Paraskevi Xepapadaki; Heather J Zar; Nikolaos G Papadopoulos
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.